Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
74.34
+2.12 (2.94%)
At close: Mar 23, 2026, 4:00 PM EDT
73.51
-0.83 (-1.12%)
After-hours: Mar 23, 2026, 7:57 PM EDT

Nektar Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
15.1244.2535.2888.2325.22
Short-Term Investments
230.64210.97268.34416.75708.74
Cash & Short-Term Investments
245.75255.23303.62504.98733.96
Cash Growth
-3.71%-15.94%-39.88%-31.20%-30.88%
Accounts Receivable
--1.215.9822.49
Inventory
--16.119.215.8
Other Current Assets
20.516.079.7815.8123.33
Total Current Assets
266.27261.29330.7545.97795.58
Net Property, Plant & Equipment
511.8236.8685.89177.54
Goodwill
---76.576.5
Long-Term Investments
3.4926.0925.83-64.83
Other Long-Term Assets
5.654.654.642.252.74
Total Assets
280.41303.85398.03710.61,117
Accounts Payable
10.7711.569.8512.989.75
Accrued Expenses
22.2729.9722.1636.5658.01
Current Portion of Leases
20.519.8719.2618.6717.44
Total Current Liabilities
53.5461.451.2768.285.2
Long-Term Leases
65.2682.798.52112.83125.74
Other Long-Term Liabilities
71.7899.02117.26162.93226.75
Total Long-Term Liabilities
137.04181.71215.78275.76352.48
Total Liabilities
190.57243.11267.05343.96437.68
Common Stock
000.020.020.02
Treasury Stock
--3---
Additional Paid-in Capital
3,8503,6603,6083,5753,517
Accumulated Other Comprehensive Income
0.020.060.08-6.91-4.16
Retained Earnings
-3,760-3,596-3,477-3,201-2,833
Shareholders' Equity
89.8360.74130.99366.64679.51
Total Liabilities & Equity
280.41303.85398.03710.61,117
Total Debt
85.75102.56117.78131.5143.18
Net Cash (Debt)
160152.66185.84373.48590.78
Net Cash Growth
4.81%-17.85%-50.24%-36.78%-35.19%
Net Cash Per Share
9.4811.1314.6729.9448.35
Book Value
89.8360.74130.99366.64679.51
Book Value Per Share
5.324.4310.3429.3955.61
Tangible Book Value
89.8360.74130.99290.14603.01
Tangible Book Value Per Share
5.324.4310.3423.2649.35
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q